---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000135"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:28:41.619887+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Labcorp Q1 revenue $3.54B (+5.8%), adjusted EPS $4.25 (+10.6%); raises FY guidance

## Summary
- Q1 diluted EPS $3.35 (+32.8% YoY); adjusted EPS $4.25 vs $3.84 consensus.
- FY2026 guidance raised: revenue growth 5.0%–6.1%, Adj. EPS $17.70–$18.35 (midpoint $18.03, +$0.13).
- Diagnostics revenue $2.76B (+5.0%); adjusted margin 16.6% (+30bps). Biopharma Labs revenue $780.6M (+8.2%).
- Operating cash flow $191.5M (vs $18.5M); free cash flow $70.5M (vs -$107.5M).
- Completed acquisition of Crouse Health lab assets; partnerships with CHOP, Illumina, Optum.ai, PathAI.

## SEC filing metadata
- accession: 0000920148-26-000135
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/0000920148-26-000135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/lh-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000135
- JSON: https://secwatch.observer/filing/0000920148-26-000135.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000135.txt

## Key facts
- Earnings Releases
  LABCORP HOLDINGS INC. reported first quarter ended March 31, 2026 results: revenue $3.54 billion, net income Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8 $ 212.8, EPS $3.35. Guidance raised.
  - Period: first quarter ended March 31, 2026
  - Revenue: $3.54 billion
  - Net income: Net Earnings Attributable to Labcorp Holdings Inc. $ 277.8 $ 212.8
  - EPS: $3.35
  - Guidance: raised
  - Result: reported results
  source text: Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance • Results from Operations for first quarter 2026 versus first quarter 2025: ◦ Revenue: $3.54 billion vs. $3.35 billion, up 5.8% ◦ Diluted EPS: $3.35 vs. $2.52, up 32.8% ◦ Adjusted EPS: $4.25 vs. $3.84, up 10.6% • Raised Full-Year Enterprise Revenue and Adjusted EPS guidance: ◦ Revenue guidance of 5.0% to 6.1%; up 20 basis points at the midpoint ◦ Adjusted EPS range of $17.70 to $18.35; up 13 cents at the midpoint
  evidence_url: https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/0000920148-26-000135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.